Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes of said gene

US Patent 11066709 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →